Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech Press South Dakota.
Press releases published on August 14, 2025
Global Pulse Oximeters Market Set to Surpass USD 7.03 Billion by 2032 | MarketsandMarkets™
GlobeNewswire
·
August 14, 2025
Delray Beach, FL, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Advanced patient monitoring solutions see rising adoption amid aging populations, chronic disease prevalence, and healthcare infrastructure expansion The global pulse oximeters market, valued at US$3.59 …
Halda Therapeutics Receives FDA Fast Track Designation for HLD-0915 for the Treatment of Metastatic Castration-Resistant Prostate Cancer
GlobeNewswire
·
August 14, 2025
NEW HAVEN, Conn., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Halda Therapeutics, a clinical-stage biotechnology company developing a novel class of therapies called RIPTAC™ Therapeutics, today announced that the U.S. Food and Drug Administration (FDA) granted Fast …
Cocrystal Pharma Reports Second Quarter 2025 Financial Results and Provides Updates on its Antiviral Drug-Development Programs
GlobeNewswire
·
August 14, 2025
Favorable CDI-988 Phase 1 safety and tolerability reported Challenge study with CDI-988 as a norovirus preventive and treatment planned later this year BOTHELL, Wash., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or …
Duos Edge AI and FiberLight Expand Strategic Partnership
GlobeNewswire
·
August 14, 2025
JACKSONVILLE, Fla., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Duos Technologies Group, Inc. (“Duos” or the “Company”) (Nasdaq: DUOT), through its operating subsidiary Duos Edge AI, Inc. (“Duos Edge AI”), a provider of adaptive, versatile and streamlined Edge Data …
Orchestra BioMed Announces Publication of AVIM Therapy Clinical Data in JACC: Advances Demonstrating Potential to Improve Cardiac Function in Patients with Hypertension and Diastolic Dysfunction
GlobeNewswire
·
August 14, 2025
Echocardiographic data analysis demonstrated favorable impact of atrioventricular interval modulation (“AVIM”) therapy on MODERATO II study patients with diastolic dysfunction, a key component in the development of heart failure with preserved ejection …
ProStar and JAVAD GNSS Announce Worldwide Distribution Deal
GlobeNewswire
·
August 14, 2025
GRAND JUNCTION, Colo., Aug. 14, 2025 (GLOBE NEWSWIRE) -- ProStar® Holdings Inc. (“ProStar®” or “the Company”) (TSXV: MAPS, OTCQX: MAPPF, FSE: 5D00), the developer of PointMan® Precision Mapping Solutions®, and JAVAD GNSS, a world leader in patented GNSS ( …
Analytics For Life Completes Clinical Study of Non-Invasive Point-of-Care Test for Elevated Pulmonary Capillary Wedge Pressure (PCWP) Using Machine Learning
GlobeNewswire
·
August 14, 2025
Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) Results build on data previously presented at ACC.25 in March 2025 TORONTO and BETHESDA, Md., Aug. …
Omegro Enters the UK Fleet Management Vertical with the Acquisition of Verilocation
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Today Omegro announced the acquisition of Verilocation, a provider of fleet management and telematics software solutions. Based in Northampton, UK, Verilocation capitalises on its deep expertise in fleet …
VYNE Therapeutics Reports 2025 Second Quarter Financial Results and Provides Business Update
GlobeNewswire
·
August 14, 2025
BRIDGEWATER, N.J., Aug. 14, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune- …
Chemomab Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
·
August 14, 2025
—Phase 3 Preparations Ongoing as Company Continues to Advance Multiple Partnering Options for Executing the Nebokitug Phase 3 Program— —Phase 2 SPRING Trial Data Highlighting Nebokitug’s Unique Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Effects …
CTW Cayman to Ring NASDAQ Opening Bell on August 18, 2025
GlobeNewswire
·
August 14, 2025
TOKYO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CTW Cayman (Nasdaq: CTW) (“CTW” or “the Company”), a leading game platform company providing global access to web-based games through its flagship HTML5 platform, G123.jp, which showcases a diverse selection of free …
PharmaTher Founder and CEO Issues Letter to Shareholders following the FDA Approval of Ketamine (KETARx™)
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company focused on unlocking the pharmaceutical potential of ketamine, announced today that Fabio …
Cycurion, Inc. Reports Financial Results for the Second Quarter of 2025
GlobeNewswire
·
August 14, 2025
MCLEAN, Va., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Cycurion, Inc. (NASDAQ: CYCU) (“Cycurion” or the “Company”), a premier cybersecurity and IT solutions provider, today announced its financial results for the second quarter and first half of 2025. Amid …
ModelOp Launches Good Decisions, a New Podcast About Human Decision Making in the Age of AI
GlobeNewswire
·
August 14, 2025
CHICAGO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- ModelOp, the leading AI lifecycle automation and governance software for enterprises, announced today the launch of its new podcast Good Decisions. From CIA officers turned CTOs to tech pioneers and data …
Healthcare Innovation Summit Africa Returns to Johannesburg - Registration Now Open
GlobeNewswire
·
August 14, 2025
JOHANNESBURG, South Africa, Aug. 14, 2025 (GLOBE NEWSWIRE) -- The Healthcare Innovation Summit Africa (HISA) 2025, Africa’s leading platform for exploring the latest trends and technologies shaping the healthcare industry, will return to Johannesburg on 22 …
CoreCard Corporation Reports Second Quarter 2025 Results
GlobeNewswire
·
August 14, 2025
NORCROSS, Ga., Aug. 14, 2025 (GLOBE NEWSWIRE) -- CoreCard Corporation (NYSE: CCRD) (“CoreCard” or the “Company”), the leading provider of innovative credit technology solutions and processing services to the financial technology and services market, …
Avicanna Reports Q2 2025
GlobeNewswire
·
August 14, 2025
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or “Company”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commercialization of plant-derived cannabinoid-based …
Evaxion announces business update and second quarter 2025 financial results
GlobeNewswire
·
August 14, 2025
COPENHAGEN, Denmark, August 14, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces second quarter 2025 financial results. …
Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference
GlobeNewswire
·
August 14, 2025
CNSide® can quantify leptomeningeal metastases (LM) over time and monitor changes in the expression of multiple targetable mutations CNSide® may catalyze LM treatment initiation, allow physicians to adapt treatment with real time shifts in tumor biology, …
nCino Announces Timing of its Second Quarter Fiscal Year 2026 Financial Results Conference Call
GlobeNewswire
·
August 14, 2025
WILMINGTON, N.C., Aug. 14, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, will report financial results for its second quarter ended July 31, 2025, after the market close on …